The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: A systematic review

Background:
Malignant bowel obstruction, a complication of certain advanced cancers, causes severe symptoms which profoundly affect quality of life. Clinical management remains complex, and outcome assessment is inconsistent.
Aim:
To identify outcomes evaluating palliative treatment for inoperable malignant bowel obstruction, as part of a four-phase study developing a core outcome set.
Design:
The review is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA); PROSPERO (ID: CRD42019150648). Eligible studies included at least one subgroup with obstruction below the ligament of Treitz undergoing palliative treatment for inoperable malignant bowel obstruction. Study quality was not assessed because the review does not evaluate efficacy.
Data sources:
Medline, Embase, the Cochrane Database, CINAHL, PSYCinfo Caresearch, Open Grey and BASE were searched for trials and observational studies in October 2021.
Results:
A total of 4769 studies were screened, 290 full texts retrieved and 80 (13,898 participants) included in a narrative synthesis; 343 outcomes were extracted verbatim and pooled into 90 unique terms across six domains: physiological, nutrition, life impact, resource use, mortality and survival. Prevalent outcomes included adverse events (78% of studies), survival (54%), symptom control (39%) and mortality (31%). Key individual symptoms assessed were vomiting (41% of studies), nausea (34%) and pain (33%); 19% of studies assessed quality of life.
Conclusions:
Assessment focuses on survival, complications and overall symptom control. There is a need for definitions of treatment ‘success’ that are meaningful to patients, a more consistent approach to symptom assessment, and greater consideration of how to measure wellbeing in this population.

Aim

To identify outcomes evaluating palliative treatment for inoperable malignant bowel obstruction, as part of a four-phase study developing a core outcome set.

Contributors

Alison Bravington, George Obita, Elin Baddeley, Miriam J Johnson, Fliss EM Murtagh, David C Currow, Elaine G Boland, Annmarie Nelson, Kathy Seddon, Alfred Oliver, Simon IR Noble and Jason W Boland

Publication

Journal: Palliative Medicine
Volume: 36
Issue: 9
Pages: 1336 - 1350
Year: 2022
DOI: 10.1177/02692163221122352

Further Study Information

Current Stage: Ongoing
Date:
Funding source(s): this work was supported by the Marie Curie Research Grants Scheme, grant number MCRGS-20171220-8020. Fliss EM Murtagh is a National Institute for Health Research (NIHR) Senior Investigator


Health Area

Disease Category: Gastroenterology

Disease Name: Malignant bowel obstruction

Target Population

Age Range: 18

Sex: Either

Nature of Intervention:

Stakeholders Involved

Study Type

- Systematic review of outcomes measured in trials

Method(s)

- Systematic review

The following databases were searched in October 2021 using strategies developed through discussion with an information retrieval specialist: the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane CENTRAL, Embase, MEDLINE and psycINFO. Additional searches were conducted through Caresearch, OpenGrey
and BASE.